Indo Rama Synthetics Q1 FY27 Results: Profit Up to ₹63.74 Cr, CMD Reappointed
Indo Rama Synthetics reported Q1 FY27 consolidated profit after tax of ₹63.74 crore, up from ₹52.75 crore in Q1 FY26. EBITDA rose to ₹108.04 crore. Mr. Om Prakash Lohia was re-appointed CMD for 3 years from Dec 26, 2026. Mr. Dharmpal Agarwal re-appointed as Independent Director for 5 years from Nov 25, 2026. 40th AGM on Sept 8, 2026.
The financial results show an improvement in profitability and key management re-appointments are significant for corporate governance and strategic direction, impacting investor confidence.
The company reported an increase in profit and EBITDA for the quarter, along with re-appointments of key management personnel, indicating stability and positive operational performance.
Indo Rama Synthetics (India) Limited announced its Un-audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, following a Board Meeting held on July 29, 2026.
The company reported a consolidated Net Profit After Tax of ₹63.74 crore for Q1 FY27, an improvement from ₹52.75 crore in Q1 FY26, despite a 28.15% decrease in total income to ₹940.20 crore compared to the previous year, attributed to geopolitical issues in West Asia. EBITDA for the quarter increased to ₹108.04 crore from ₹100.27 crore in Q1 FY26, driven by improved margins and product mix.
Key management changes were also approved. Mr. Om Prakash Lohia was re-appointed as Chairman and Managing Director for a further period of 3 years, effective from December 26, 2026, to December 25, 2029, subject to shareholder approval. Additionally, Mr. Dharmpal Agarwal was re-appointed as an Independent Director for a second term of 5 years, from November 25, 2026, to November 24, 2031, also subject to shareholder approval at the upcoming 40th Annual General Meeting (AGM).
The Board also approved the re-constitution of the Stakeholders Relationship Committee. The 40th AGM is scheduled to be held on Tuesday, September 8, 2026, through Video Conferencing/OAVM. The company will also be publishing an extract of its Un-audited Financial Results for the quarter ended June 30, 2026, on its website.
What to do with a filing like this
Indo Rama Synthetics (India) Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indo Rama Synthetics (India) Limited. Read the original for the full detail.